OrbiMed’s Crinetics Pharmaceuticals CRNX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $33M | Buy |
1,149,000
+150,000
| +15% | +$4.31M | 0.83% | 30 |
|
|
2025
Q1 | $33.5M | Hold |
999,000
| – | – | 0.8% | 35 |
|
|
2024
Q4 | $51.1M | Sell |
999,000
-51,055
| -5% | -$2.61M | 1.05% | 28 |
|
|
2024
Q3 | $53.7M | Sell |
1,050,055
-230,745
| -18% | -$11.8M | 0.98% | 30 |
|
|
2024
Q2 | $57.4M | Sell |
1,280,800
-104,200
| -8% | -$4.67M | 1.13% | 27 |
|
|
2024
Q1 | $64.8M | Sell |
1,385,000
-282,360
| -17% | -$13.2M | 1.19% | 27 |
|
|
2023
Q4 | $59.3M | Sell |
1,667,360
-1,228,714
| -42% | -$43.7M | 1.18% | 31 |
|
|
2023
Q3 | $86.1M | Sell |
2,896,074
-1,054,722
| -27% | -$31.4M | 1.83% | 14 |
|
|
2023
Q2 | $71.2M | Hold |
3,950,796
| – | – | 1.29% | 28 |
|
|
2023
Q1 | $63.4M | Buy |
3,950,796
+753,920
| +24% | +$12.1M | 1.25% | 24 |
|
|
2022
Q4 | $58.5M | Hold |
3,196,876
| – | – | 1.12% | 33 |
|
|
2022
Q3 | $62.8K | Hold |
3,196,876
| – | – | 1.17% | 30 |
|
|
2022
Q2 | $59.6K | Hold |
3,196,876
| – | – | 1.08% | 30 |
|
|
2022
Q1 | $70.2M | Hold |
3,196,876
| – | – | 1.14% | 31 |
|
|
2021
Q4 | $90.8M | Buy |
3,196,876
+200,000
| +7% | +$5.68M | 1.17% | 31 |
|
|
2021
Q3 | $63.1M | Hold |
2,996,876
| – | – | 0.69% | 46 |
|
|
2021
Q2 | $56.5M | Buy |
2,996,876
+243,309
| +9% | +$4.59M | 0.57% | 51 |
|
|
2021
Q1 | $42.1M | Hold |
2,753,567
| – | – | 0.39% | 69 |
|
|
2020
Q4 | $38.9M | Hold |
2,753,567
| – | – | 0.34% | 70 |
|
|
2020
Q3 | $43.1M | Hold |
2,753,567
| – | – | 0.54% | 56 |
|
|
2020
Q2 | $48.2M | Buy |
2,753,567
+714,285
| +35% | +$12.5M | 0.68% | 46 |
|
|
2020
Q1 | $30M | Hold |
2,039,282
| – | – | 0.5% | 54 |
|
|
2019
Q4 | $51.2M | Hold |
2,039,282
| – | – | 0.73% | 44 |
|
|
2019
Q3 | $30.7M | Hold |
2,039,282
| – | – | 0.58% | 49 |
|
|
2019
Q2 | $51M | Buy |
2,039,282
+125,000
| +7% | +$3.12M | 0.79% | 39 |
|
|
2019
Q1 | $43.6M | Hold |
1,914,282
| – | – | 0.67% | 43 |
|
|
2018
Q4 | $57.4M | Hold |
1,914,282
| – | – | 1.06% | 30 |
|
|
2018
Q3 | $54.8M | Buy |
+1,914,282
| New | +$54.8M | 0.66% | 44 |
|